Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to 5.46.

  • Northwest Biotherapeutics' Interest Coverage Ratio rose 2322.0% to 5.46 in Q3 2025 from the same period last year, while for Sep 2025 it was 7.6, marking a year-over-year increase of 2148.84%. This contributed to the annual value of 8.56 for FY2024, which is 1915.02% up from last year.
  • As of Q3 2025, Northwest Biotherapeutics' Interest Coverage Ratio stood at 5.46, which was up 2322.0% from 8.09 recorded in Q2 2025.
  • In the past 5 years, Northwest Biotherapeutics' Interest Coverage Ratio ranged from a high of 5.46 in Q3 2025 and a low of 15.37 during Q2 2021
  • For the 5-year period, Northwest Biotherapeutics' Interest Coverage Ratio averaged around 10.21, with its median value being 10.37 (2024).
  • Per our database at Business Quant, Northwest Biotherapeutics' Interest Coverage Ratio tumbled by 11604.7% in 2021 and then skyrocketed by 5226.36% in 2022.
  • Northwest Biotherapeutics' Interest Coverage Ratio (Quarter) stood at 9.26 in 2021, then crashed by 60.79% to 14.89 in 2022, then rose by 18.11% to 12.19 in 2023, then skyrocketed by 39.01% to 7.44 in 2024, then increased by 26.52% to 5.46 in 2025.
  • Its Interest Coverage Ratio was 5.46 in Q3 2025, compared to 8.09 in Q2 2025 and 10.81 in Q1 2025.